Emmaus Life Sciences (EMMA) Convertible Debt (2011 - 2023)
Emmaus Life Sciences' Convertible Debt came in at $1 million for Q1 2023, down 68.3% from $3.15 million a year earlier and down 95.2% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Convertible Debt (2011 - 2023) Analysis & Trends
At the end of FY2022, Emmaus Life Sciences' Convertible Debt was $21 million, up 566.7% from FY2021.
- Convertible Debt carries a four-year compound annual growth rate of 39.9% (FY2018 to FY2022).
- Going back by year, Convertible Debt was $3.15 million in FY2021 (unchanged), $3.15 million in FY2020 (-90.1%), $31.8 million in FY2019 (+479.8%) and $5.49 million in FY2018.
- The Q1 2023 figure represents the lowest quarterly Convertible Debt since Q1 2020.
- Year-over-year, Convertible Debt increased in five of the last eight quarters, with growth averaging 142.4%.
- The fastest year-over-year change in Convertible Debt over five years came in Q2 2020 (growth of 600.0%), and the weakest in Q4 2020 (a decline of 90.1%).
- Business Quant data shows EMMA's Convertible Debt at $21 million (Q4 2022), $18.4 million (Q3 2022) and $20.6 million (Q2 2022) in the three quarters before Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Emmaus Life Sciences | 4.21 Mn | -2.09 Mn | 5.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 21.00 Mn |
| Sep 30, 2022 | 18.40 Mn |
| Jun 30, 2022 | 20.60 Mn |
| Mar 31, 2022 | 3.15 Mn |
| Dec 31, 2021 | 3.15 Mn |
| Sep 30, 2021 | 12.91 Mn |
| Jun 30, 2021 | 12.53 Mn |
| Mar 31, 2021 | 12.11 Mn |
| Dec 31, 2020 | 3.15 Mn |
| Sep 30, 2020 | 3.15 Mn |
| Jun 30, 2020 | 3.15 Mn |
| Mar 31, 2020 | 886,000.00 |
| Dec 31, 2019 | 31.80 Mn |
| Sep 30, 2019 | 706,000.00 |
| Jun 30, 2019 | 450,000.00 |
| Mar 31, 2019 | 389,000.00 |
| Dec 31, 2018 | 5.49 Mn |
| Mar 31, 2015 | 1.92 Mn |
| Dec 31, 2014 | 1.51 Mn |
API Access
Emmaus Life Sciences Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();